Home  »  Finance   »  Roll up the Sleeves! When the bell rang at previou...

Roll up the Sleeves! When the bell rang at previous close Zomedica Corp. (ZOM) was down -6.69%

Let’s start up with the current stock price of Zomedica Corp. (ZOM), which is $0.21 to be very precise. The Stock rose vividly during the last session to $0.24 after opening rate of $0.23 while the lowest price it went was recorded $0.22 before closing at $0.23.Recently in News on September 13, 2022, Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform. Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering novel diagnostic and therapeutic products for companion animals, today announced the commercial launch of its newest assay – Free T4 (fT4) – for the TRUFORMA In-Clinic Biosensor Testing Platform. You can read further details here

Zomedica Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.5000 on 02/17/22, with the lowest value was $0.1750 for the same time period, recorded on 05/12/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Zomedica Corp. (ZOM) full year performance was -55.05%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Zomedica Corp. shares are logging -66.35% during the 52-week period from high price, and 21.14% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.17 and $0.63.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4948534 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Zomedica Corp. (ZOM) recorded performance in the market was -25.87%, having the revenues showcasing -5.33% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 218.18M, as it employees total of 47 workers.

Analysts verdict on Zomedica Corp. (ZOM)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2562, with a change in the price was noted -0.04. In a similar fashion, Zomedica Corp. posted a movement of -14.37% for the period of last 100 days, recording 19,631,738 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ZOM is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Zomedica Corp. (ZOM): Technical Analysis

Raw Stochastic average of Zomedica Corp. in the period of last 50 days is set at 3.17%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.76%. In the last 20 days, the company’s Stochastic %K was 21.40% and its Stochastic %D was recorded 31.69%.

Let’s take a glance in the erstwhile performances of Zomedica Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -25.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -36.45%, alongside a downfall of -55.05% for the period of the last 12 months. The shares increased approximately by -1.26% in the 7-day charts and went up by -15.57% in the period of the last 30 days. Common stock shares were lifted by -5.33% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts